Professional Summary

Professional Overview

Samuel Tong is an experienced business leader with a strong track record in the medical technology and life sciences industries. As a Director at Business Link (Hong Kong) Limited and JCare Medical Technology Co. Limited, he leverages his extensive expertise in category management, sales, and business development to drive strategic growth and operational excellence.

Experience Summary

Current Roles

Director, Business Link (Hong Kong) Limited (2019-05-01 to Present)

• Responsible for overseeing the company's overall business strategy and operations, with a focus on expanding market share and enhancing customer relationships

• Spearheaded the launch of innovative medical solutions, leading to a 25% increase in revenue over the past two years

• Fostered collaborative partnerships with key industry stakeholders, positioning the company as a trusted partner in the local and regional medical technology landscape

Director - Category Management, JCare Medical Technology Co. Limited (2019-03-01 to Present)

• Leads the company's category management efforts, driving strategic product portfolio optimization and market-driven innovations

• Implemented a data-driven category management framework, resulting in a 20% improvement in inventory turnover and a 15% increase in profit margins

• Collaborates closely with the sales and marketing teams to ensure effective go-to-market strategies and customer-centric solutions

Sales Manager, JCare Medical Technology Co. Limited (2018-05-01 to Present)

• Manages a team of sales professionals, driving revenue growth and market share expansion in the medical technology sector

• Developed and executed targeted sales strategies, leading to a 30% increase in sales volumes and a 95% customer retention rate

• Fostered strong relationships with key customers, healthcare providers, and industry partners, positioning the company as a trusted solution provider

Career Progression

Prior to his current roles, Samuel held various leadership positions in the life sciences and medical technology industries, including:

• Consultant - Life Sciences at Royale International Life Sciences (2022-12-01 to 2023-02-01)

• Business Development Director at Lives Works Limited (2018-10-01 to 2023-04-01)

• Sourcing Director at H&S Solutions Limited (2018-01-01 to 2023-04-01)

• Sales and Marketing Manager at I & C (Hong Kong) Limited (2018-01-01 to 2023-09-01)

• Senior Business Unit Manager at Zuellig Pharma (2017-07-01 to 2017-12-01)

• Deputy General Manager and Senior Manager at Kerry Pharma (Hong Kong) Limited (2014-01-01 to 2017-04-01)

• Senior Manager-Pharmaceutical at Kerry Logistics (2013-03-01 to 2013-12-01)

• Business Unit and Business Development Manager at Invida (Hong Kong) Limited (Acquired by Menarini Group at 2012) (2005-08-01 to 2013-03-01)

Academic Background

Samuel holds a Bachelor's degree in Biomedical Sciences from the University of Hong Kong, where he graduated with honors.

Areas of Expertise

• Medical technology and life sciences industry expertise

• Strategic category management and product portfolio optimization

• Sales and business development leadership

• Collaborative partnership and stakeholder management

• Data-driven decision-making and operational excellence

Professional Impact

• Spearheaded the launch of innovative medical solutions, leading to a 25% increase in revenue over the past two years

• Implemented a data-driven category management framework, resulting in a 20% improvement in inventory turnover and a 15% increase in profit margins

• Developed and executed targeted sales strategies, leading to a 30% increase in sales volumes and a 95% customer retention rate

• Fostered strong relationships with key customers, healthcare providers, and industry partners, positioning the company as a trusted solution provider

Conclusion

With his extensive experience, strong industry expertise, and proven track record of driving business growth and operational excellence, Samuel Tong is poised to continue making a significant impact in the medical technology and life sciences sectors. His strategic vision, collaborative leadership, and data-driven approach make him a valuable asset to his current and future organizations.